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ABSTRACT
Osteoblasts, which orchestrate the deposition of small apatite crystals through the expression of nucleating proteins, have been shown
to also express clock genes associated with the circadian signaling pathway. We hypothesized that protein‐mediated bone
mineralizationmay be linked to circadian oscillator mechanisms functioning in peripheral bone tissue. In this study, Per1 expression in ex
vivo neonatal murine calvaria organ cultures was monitored for 6 days using a Per1‐luciferase transgene as a bioluminescent indicator of
clock function. Fluctuations in Per1 expression had a period of 25 4 hours (n¼ 14) with early expression at CT09:59 03:37
(CT¼ circadian time). We also established the kinetics ofmineral deposition in developing bone by using noninvasive Ramanmicroscopy
to track mineral accumulation in calvarial tissue. The content and quality of newly deposited mineral was continually examined at the
interparietal bone/fontanel boundary for a period of 6 days with 1‐hour temporal resolution. Using this approach, mineralization over
time exhibited bursts of mineral deposition followed by little or no deposition, which was recurrent with a periodicity of 26.8 9.6 hours.
As many as six near‐daily mineralization events were observed in the calvaria before deposition ceased. Earliest mineralization events
occurred at CT16:51 03:45, which is 6 hours behind Per1 expression. These ﬁndings are consistent with the hypothesis that
mineralization in developing bone tissue is regulated by a local circadian oscillator mechanism. © 2013 American Society for Bone and
Mineral Research.
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Introduction
Mammalian circadian rhythms are controlled by a negativefeedback mechanisms involving clock genes. A circadian
system functions in three parts: (1) a timing cue, (2) a circadian
oscillator, and (3) a rhythmic physiological response.(1) The
master regulator for presumably all circadian rhythms in the
body has been identiﬁed as the suprachiasmatic nucleus (SCN),
located in the hypothalamus.(2) The SCN receives timing cues
from retinal nerves sensitive to day/night light‐level ﬂuctuations
and responds by sending rhythmic neural and humoral signals to
the body.(3–6) Circadian oscillators also reside in peripheral
tissues, where they receive timing cues from the SCN and direct
the rhythmic expression of other downstream genes. Mammali-
an circadian oscillators consist of a nuclear complex composed of
three PERIOD (PER1, PER2, and PER3) and two Cryptochrome
(CRY1 and CRY2) proteins that are activated by the CLOCK:BMAL
heterodimeric transcription factor.(7) Once induced, the PER/CRY
complex suppresses CLOCK:BMAL transcriptional activity, there-
by halting the production of PER and CRY proteins.(8) With the
turnover of PER/CRY, the CLOCK:BMAL complex is reactivated to
start a new cycle.(9)
Musculoskeletal tissues, including vertebral bone,(10) craniofa-
cial bone,(11,12) isolated osteoblasts,(13) and skeletal muscle,(14) all
exhibit circadian expression of Per and Cry genes. Although
peripheral circadian oscillators have been implicated in the
physiological functions of various tissues,(15–19) the extent of
their inﬂuence is unknown. CLOCK:BMAL transcribes a variety of
downstream targets, collectively termed clock‐controlled genes
(CCGs). CCGs that encode other transcription factors amplify
the number of cycling genes and are able to inﬂuence other
cells, tissues, and extracellular processes.(20) Secondary negative
feedback loops created by CCGs are capable of modifying the
downstream circadian effect in phase and amplitude. Therefore,
the circadian network has the potential to inﬂuence a
physiological pathway at several points.(21) In bone tissue, the
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role of circadian oscillators has been implicated in bone turnover,
humoral signaling, and fracture healing.(22–24) Furthermore,
deletion of Per1, Per2, and Bmal1 genes increases bone
mass.(13) However, the relationship between clock gene function
and mineralization remains a relatively new and little explored
research topic. Understanding the relationship between bone
cell function and the circadian network may be integral to
understanding the physiological process of ossiﬁcation.
Bone mineralization is a protein‐mediated process. The
mechanistic steps required for calcium phosphate mineral
formation are thought to be regulated by several genes
including Bsp (bone sialoprotein), Dmp1 (dentin matrix protein
1), Bglap2 (osteocalcin), and Spp1 (osteopontin). Each of these
proteins can directly interact with growing mineral using
domains containing repeated acidic residues. These proteins
may function as either nucleators or inhibitors to mineraliza-
tion.(25) However, the mechanisms of bone mineralization are
currently not well understood, and as the intricacies of the
mineralization process are elucidated a clearer understanding of
protein function will evolve.(26,27)
Modern analytical techniques for studying mineralization in
situ are revealing more speciﬁc roles for these proteins.
Nudelman and colleagues(28) proposed that uptake of calcium
phosphate clusters into the collagen ﬁbril is regulated by tuning
the electrostatics of the clusters with negatively charged protein
segments. These protein segments are then directed to binding
sites within the gap regions, where the calcium phosphate
clusters nucleate into apatitic mineral. Some investigators
suggest that mineral does not form an apatitic phase directly,
but rather passes through an intermediate solid phase stabilized
by nucleating proteins.(28–30) The existence of this intermediate is
currently debated.(30,31)
We hypothesize that bone mineralization is linked in part
to regulated protein expression by peripheral oscillators within
the circadian network. Identifying a link between these two
physiological processes may have clinical relevance, because the
search formore effective anabolic agents relies heavily on known
mechanisms of ossiﬁcation. The present study was designed to
determine, with high temporal resolution, the kinetics of mineral
activity by continuously monitoring mineral deposition in
neonatal murine calvarial tissue using Raman microscopy.
Here we report that mineral deposition in calvarial organ
cultures shows an approximately 24‐hour periodicity and can be
correlated with clock gene activity.
Materials and Methods
Specimens
All procedures involving mice conformed to an Institutional
Animal Care and Use Committee‐approved protocol. Colonies of
C57/Bl6 mice were purchased from Charles River Laboratories
(Wilmington, MA, USA). B6.BTBR‐Tg(Per1‐luc,Per1)1Jt/J mice, a
transgenic line that harbors ﬁreﬂy luciferase under the control of
a 6.75‐kb Per1 promoter (Per1‐Lucmice),(32) were purchased from
The Jackson Laboratory (Bar Harbor, ME, USA). All mice were
housed in University of Michigan animal facilities and subjected
to a 12/12‐hour light/dark (LD) cycle throughout gestation.
Within 24 hours of birth, neonatal mice were collected and
sacriﬁced. Calvaria including frontal, parietal, and interparietal
plates were harvested with brain and soft tissue removed. The
fontanel region remained intact. Circadian time (CT) was deﬁned
by the LD cycle used before sacriﬁce, with CT00:00 and CT12:00
corresponding to the beginning and end of the light period. Time
of sacriﬁce was consistently CT05:00 regardless of the time of
birth. This timing convention was used postmortem.
Ex vivo organ culture
During tissue preparation, calvaria were cultured in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM, which contains 1.8mM Caþ2,
0.916mMPO4
3) under standard growth conditions (5%CO2, 37°C,
90% humidity). Six‐well cell culture dishes (In Vitro Scientiﬁc,
Sunnyvale, CA, USA) ﬁtted with #1 glass windows in the bottom
of each well were used in all experiments. Sapphire ﬂats (12‐mm‐
diameter, 1‐mm‐thick; Esco Products, Inc., Oak Ridge, NJ, USA)
were placed on top of the glass windows. Calvaria were placed
on the sapphire, brain‐side up, with cuts made radially with a
scalpel to allow for ﬂattening of the tissue. A 316‐stainless‐steel
mesh screen and washer (Small Parts Inc., Seattle, WA, USA) were
placed on top of the calvaria for 4 hours until tissue remained ﬂat,
and then removed. Tissue was then stained with alizarin red
(1 µg/mL) for 30 minutes and then washed in growth medium. In
each well, a custom tissue immobilizer device made with 316‐
stainless‐steel was used to anchor the specimen at a single point
(Fig. 1A, B). The growthmediumwas removed and differentiation
medium containing DMEM, 10% fetal bovine serum, 100 µg/mL
streptomycin, 100 units/mL penicillin, 100 µg/mL ascorbic acid
phosphate, and 10mM b‐glycerol phosphate was used through-
out the rest of the experiment.(33) The addition of differentiation
medium marked time‐zero for time‐series experiments. Medium
for Per1‐luc murine calvaria was supplemented with 50 µg/mL
luciferin for bioluminescence experiments. LD cycling was
replaced with continuous dark (DD) for all organ cultures and
maintained throughout the experiments.
RNA isolation and RT‐PCR
Total RNA was isolated using Trizol reagent (Invitrogen). Two
micrograms of total RNA was reverse transcribed using TaqMan
reverse transcriptase (Applied Biosystems, Foster City, CA, USA)
for cDNA synthesis. Quantitative real‐time polymerase chain
reaction (PCR) detection of Per1, Per2, Dbp, and ClockmRNAs was
carried out as described previously(34) using predeveloped
TaqMan probes and an ABI PRISM 7700 sequence detector
(Applied Biosystems). The mRNA expression for each gene was
calculated based on a relative standard curve and normalized to
glyceraldehyde‐3‐phosphate dehydrogenase mRNA (GAPDH).
Raman instrumentation
Mineral deposition in C57/Bl6 murine calvarial tissue was
observed using a custom‐built Raman inverted microscope.
The Raman microscope consisted of an inverted microscope
(Eclipse Ti; Nikon USA, Melville, NY, USA) with the beam‐shaping
lenses removed from the rear port. Collimated 830‐nm laser light
was directed through the rear port and focused on the specimen
through an inﬁnity‐corrected 20 /0.45 numerical aperture (NA)
objective (Nikon USA). Raman scattered light was collected
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through the rear port and focused through a 50‐µm slit into a
spectrograph (HoloSpec; Kaiser Optical Systems, Inc., Ann Arbor,
MI, USA) using a 200‐mm achromatic tube lens and ultimately
imaged using a back‐illuminated deep‐depletion charge‐cou-
pled device (CCD) (Classic CCD; Andor Technologies, South
Windsor, CT, USA). Spectral resolution was 6 to 8 cm1. By
digitally resolving spectral bands, differences in wave number
shift of<1 cm1 could be detected. Digital resolution of spectral
bands in the 900 to 1010 cm1 region was performed by band
ﬁtting the spectra to Gaussianþ Lorentzian functions using a
nonlinear least‐squares technique described in Press and
colleagues(35) and implemented in MATLAB (Math Works, Natick,
MA, USA).(36)
Organ cultures containing calvaria and medium were main-
tained under standard culture conditions throughout the
experiment in a stage incubation chamber (LiveCell; Pathology
Devices, Inc., Westminster, MD, USA). The microscope was ﬁtted
with a computer‐controlled x‐y‐z stage (Proscan II; Prior Scientiﬁc,
Rockland, MA, USA) with <1 µm spatial resolution. Raman
spectra were taken simultaneously on up to four calvaria by
interrogating each specimen every hour for 120 to 140 hours.
Calvaria were positioned so that the laser line illuminated
the interparietal bone/fontanel interface perpendicular to the
sagittal plane. The quantity of mineral deposition in bone
collagen was measured as the phosphate n1 Raman band height
at 957 cm1 using the phenylalanine band height at 1001 cm1
as an internal measure of matrix content. Mineralization rates
were determined by applying a quadratic least‐squares time
derivative (Savitzky‐Golay, 13 point) of the mineral‐to‐matrix
data. The crystalline phase of the mineral was measured using
the phosphate n1 band position. Mineral with a band centered at
957 to 960 cm1 was considered to be apatitic. Crystallinity, a
combined measure of crystal size and perfection, was measured
as the inverse of the phosphate n1 band width (at 957 cm
1).
Crystallinity is measured in units of nanometers (nm), corre-
sponding to crystal domain size in the c‐axis; however, because
of lattice substitutions distorting the structure, this measure is
best interpreted as a lower limit to domain size. The actual
crystallite size may be larger.
Bioluminescence imaging
Bioluminescence of Luc gene coexpression in transgenic murine
calvaria was followed with an ultralow noise electronmultiplying
CCD (EMCCD) (iXon, 512 512 pixels; Andor Technologies,
Windsor, CT, USA) with 16 16 pixel binning, attached to one
port of the microscope. A 0.5 magniﬁcation relay optic was
used to reduce the image to increase the amount of light per
pixel. Tissue was imaged using a 10 0.5 NA objective (Nikon
USA) with 14‐minute acquisition. Fluorescence images of
alizarin‐stained calvaria were also performed with the same
EMCCD channel with the addition of a mercury lamp excitation
source and a ﬁlter cube (TRITC‐A‐NTE; Semrock, Rochester,
NY, USA). The Raman illumination region was determined by
imaging the laser spot on the tissue.
Results
Bone formation was observed in an ex vivo tissue culture system,
which allowed examination of active mineralization areas in
neonatal calvaria over periods of up to a week. Mineralization
activity in this model was initially veriﬁed by culturing calvarial
tissue for 0, 2, 4, 6, and 8 days, followed by staining with alizarin
red and ﬂuorescence imaging of the fontanel region. Analysis of
the calvarial images in Fig. 1C–G showed that the integrated area
of the posterior fontanel decreased continually over 8 days
(summarized in Fig. 1H). There was no mineral detected within
the fontanel region to suggest nonspeciﬁc mineralization of the
tissue. However, mineral deposition was conﬁned to the fontanel
perimeter, which was observed over time as an inward moving
bone edge, as would be expected of an advancing mineral front
along the interparietal and parietal bone edges. The pattern of
Fig. 1. Ex vivomurine calvarial organ culture. (A) Tissue immobilizing device used to hold the interparietal bone by a single point in a six‐well plate (plate
shown in B). White light images of alizarin‐stained calvarial tissue showing posterior fontanel closure after (C) 0, (D) 2, (E) 4, (F) 6, and (G) 8 days of culture.
Labels i and p in C indicate interparietal and parietal bones. (H) Bar chart shows quantitative results of fontanel area measured in image pixels over 8 days.
Confocal ﬂuorescence images of alizarin‐stained calvaria at the (I) interparietal and (J) parietal bone edge with the bar showing 100‐µm scale.
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bone formation at the parietal bone edge was highly porous and
divided, whereas the interparietal bone edge was more uniform
(Fig. 1I and J). We limited our study to mineralization occurring at
the interparietal bone edge.
Detection of clock gene activity in isolated calvarial organ
cultures
To determine if clock genes were active in calvarial organ
cultures, we measured mRNA levels of Period1 (Per1), Period2
(Per2), Clock (Clk), and D‐box binding protein (DBP) in isolated
tissues. All four transcripts were detected, although we did not
attempt to directly measure if levels varied in a circadian
pattern (Fig. 2A). In several tissues, circadian oscillators
continue to function even when the tissue has been put in
organ culture and removed from central SCN regulation.(32) To
determine if the circadian oscillator in calvaria could function in
organ cultures, we isolated calvaria from B6.BTBR‐Tg(Per1‐luc,
Per1)1Jt/J transgenic mice. Dual‐channel images using ﬂuore-
scence and bioluminescence techniques provided spatial
maps for relative Per1 expression levels in the posterior
fontanel region (Fig. 2B). Calvaria were stained with alizarin
red before culturing to show clear mineralization boundaries
of the two parietal bones and the interparietal bone
surrounding the posterior fontanel and imaged with the
ﬂuorescence channel. Bioluminescence images were taken
immediately afterward, with no excitation source. Spatial maps
of six Per1‐Luc calvarial tissue sections at T¼ 0 showed
ubiquitous expression of the luciferase reporter in the calvaria,
whereas three wild‐type controls showed baseline biolumi-
nescence. Per1 expression was highest within the fontanel
region. There was a signiﬁcant reduction in luciferase activity
at the interparietal bone edge (indicated as black line in
Fig. 2B) with only moderate expression inside the bone region.
Bioluminescence from Per1‐Luc was monitored longitudinally
in 14 ex vivo calvarial cultures for 6 days. Time series data of the
integrated signal showed peak expression of Per1 in nine of the
specimens with periodicity persisting for up to 6 days. These
specimens had periods ranging from 18 hours to 28 hours with
an average period of 25 4 hours. An example of Per1‐Luc
bioluminescence over time is shown in Fig. 2C. Per1 expression in
this specimen has a 27‐hour period starting in the middle of the
light period (CT07:26, circadian time) and gradually shifting to
Fig. 2. Clock gene expression in ex vivo calvarium culture. (A) Reverse‐transcriptase PCRmeasurements ofmRNA expression of Per1, Per2, Clock, and DBP
from calvarial tissue cultures, normalized to GAPDH. (B) Fluorescence and bioluminescence images of Per1:Luc and wild‐type calvarial tissue sections at
T¼ 0. Fluorescence and bioluminescence images are shown in grayscale with white representing mineralized tissue and Per1 expression, respectively.
Black lines represent interparietal bone edge. White arrowheads indicate placement of Raman probe. (C) Bioluminescence intensity for Per1:Luc calvarial
sections in circadian time. Black and white bars indicate dark and light times during gestation.
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the middle of the dark period (CT19:55) over the 6‐day
observation. Five calvaria did not show continued expression
beyond one cycle and therefore were not useful for measuring
periodicity.
Measurement of calvarial mineralization by Raman
spectroscopy
Active mineral deposition in regions of new bone formation was
observed by Raman microscopy. Figure 3A shows time‐series
Raman spectra observed near the interparietal bone edge of a
calvarium section. The PO4
3–band at 957 cm1 is characteristic of
newly deposited apatitic minerals and increased over 6 days. The
amino acid residues phenylalanine (Phe, 1001 cm1), proline
(Pro, 850 and 925 cm1), and hydroxyproline (Hyp, 875 and 940
cm1), which are components of the organic matrix, showed
little variation and no signiﬁcant change in intensity throughout
the experiment. Therefore, tissue mineral content could be
measured as the ratio of the PO4
3–band height to the Phe band
height (mineral‐to‐matrix). Similar time‐series plots collected at
1‐hour intervals comprise the data used for analysis of mineral
deposition reported in this study.
Figure 3A also shows that the mineral band position is time‐
independent, or at least varies less than we canmeasure by band
ﬁtting (approximately 0.2 cm1). Thus, our measurements are
silent on the long‐running discussion over the presence or
absence of intermediate forms of mineral that precede
hydroxyapatite formation. At most, we can say that such forms,
if they exist, decay to an apatitic form in less time than the 1‐hour
interval between samples.
As noted in Fig. 1, the mineralization front gradually advances
over time from the interparietal bone edge inward to the
fontanel region. To determine if this advancing front could
be detected by Raman measurements, time sequence spectra
were taken at several points near the initial position interparietal
bone edge. Measurements were taken along a line perpendicular
to the edge (see Fig. 3B) at regular intervals of 25 µm beginning
within the mineralized region and extending into the fontanel.
Figure 3C shows complete spectra taken for each position at
the beginning of the experiment, whereas Fig. 3D shows kinetic
proﬁles of mineral deposition (mineral‐to‐matrix ratio) at each
position with negative positions corresponding to regions
within bone and positive positions to fontanel. At time zero,
the 940 cm1 collagen band and the 1003 cm1 phenylalanine
band, which at this point is predominantly from noncollagenous
proteins, are seen in all spectra (Fig. 3A). The edge of the bone
shows a small amount of the mineral band at 957 cm1, but is
barely resolvable from background. In the fontanel there is no
discernible mineral band; but mineral is observed in the bone
region away from the edge having a Raman spectrum with a
well‐deﬁned 957 cm1 band. Although the fontanel region
showed no discernible mineral signal, we cannot rule out the
possibility of trace mineral deposited prior to time zero. It is also
not clear whether the presence of prior mineral has any effect on
later mineral dynamics. Net mineral gain was consistently
Fig. 3. Mineral deposition observed by Raman spectroscopy. (A) Overlay of Raman spectra of the interparietal bone edge with 10‐hour time intervals,
normalized to the Phe band. (B) Fluorescence image of amurine calvarium in culture at T¼ 0with eight Raman probe positions near the interparietal bone
edge indicatedwithwhite dots. (C) Overlay of Raman spectra at each probe position at T¼ 0. (D) Time‐series data ofmineral depositionwith distances from
the interparietal bone edge indicated.
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observed over time at each position. Those positions in the
fontanel region showed delayedmineral deposition correspond-
ing to the distance from the initial edge, which supports the
model of inward bone growth into a previously unmineralized
fontanel region.
Circadian regulation of mineralization
In a Raman study of 10 neonatal murine calvaria, the probe was
positioned within 50 µm of the interparietal bone/fontanel
boundary (white arrowheads in Fig. 2B) on the unmineralized
fontanel side, and mineralization was observed for 6 days with
1‐hour time intervals. Raman spectra showed evidence of
mineralization as an increase in the intensity of the bone mineral
phosphate Raman signal (957 cm1) through the course of the
experiment. In six calvaria, circadian periodicity was clearly seen
in mineral formation rate. Mineral deposition occurred in bursts
followed by intervals of low deposition or no deposition. In the
recorded data, mineralization is seen as stair‐step increases of
themineral‐to‐matrix ratio over time (Fig. 4A). Mineralization rate
was measured as the time‐derivative (see Fig. 4B). Fluctuating
mineralization resulted in peaks and troughs. We were able to
observe between two and six bursts over the 6‐day period. The
average period measured as the peak‐to‐peak time was 26.8
 9.6 hours. Specimens that displayed one or no mineral event
were not included in the analysis.
To estimate the phase delay between Per1 expression and
increased mineral activity, we compared the times of the earliest
maximum bioluminescence and maximum mineralization rate
after sacriﬁce. Per1 expression andmineralizationweremeasured
independently. The ﬁrst maxima of Per1 expression across
calvaria (n¼ 14) occurred at CT09:59 03:37. The ﬁrst minerali-
zation event occurs at CT16:51 03:45. This mineralization lags
approximately 7 hours behind Per1 expression (p¼ 0.004).
Figure 5 shows the relative times of Per1 expression and
mineralization in a 24‐hour clock format.(37)
Aperiodic changes in mineral crystallinity
The ﬁrst mineral detected along the interparietal bone edge
spectroscopically resembles small apatitic crystallites. In the early
hours of observation the mineral phosphate has a characteristic
PO4
3–Raman band centered at 957 cm1 (Fig. 3A). This band
position is consistent with previous Raman studies on young
bone,(29) but contrasts with more mature bone mineral, which
typically has a band centered at 959 cm1.(36) The band center
remains constant as mineral accumulates. However, crystallinity
is initially 14 2.5 nm and increases almost linearly at an average
rate of 0.068 0.021 nm/h and then reaches a plateau at
21.7 2.6 nm with no further change (Fig. 4C). Similar aperiodic
behavior was repeatedly observed across calvaria displaying
periodic growth (n¼ 6). These results suggest that there is a
crystallinity limit achievable in this tissue system, although it is
not always reached within 6 days.
Discussion
Here we show the ﬁrst direct evidence for circadian periodicity
in mammalian bone mineralization. Neonatal murine calvarial
organ cultures demonstrated in vitro mineralization and thereby
facilitated the tracking of mineralization kinetics. Cyclic events
were observed as pulses of heightened mineralization occurring
periodically with an interval of approximately 1 day. Per1
expression conﬁrms the presence and operation of the clock
genes functioning in calvarial tissue. In previous studies,
circadian clock gene activity was observed for up to 30 days in
SCN organ cultures, and peripheral clock function was detected
for up to 7 days in isolated lung, liver, and skeletal muscle
tissues.(14) We observed circadian Per1 expression in calvarial
organ cultures for up to 6 days, consistent with previous
observations with other peripheral clocks in organ culture.
Although circadian rhythms in bone formation has been inferred
from ﬂuctuating biomarkers and metabolites, periodicity in the
biosynthesis of bone mineral has not previously been measured.
Fig. 4. Mineral deposition at the interparietal bone/fontanel boundary
in ex vivo calvarial tissue measured by Raman spectroscopy. (A) Circadian
time dependence of the mineral‐to‐matrix ratio (amount) with
segmented line (solid) illustrating incremental increases in tissue mineral
content. (B) Circadian time dependence of deposition rate, with black and
white bars indicating dark and light times during gestation. (C) Time
dependence of mineral crystallinity.
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The timed expression of the Per1 gene in murine calvarial
tissue is consistent with previous reports of clock genes in other
peripheral tissue. Because much of the mammalian clock
mechanism has been elucidated, we can suggest how bone
mineralization ﬁts into the circadian process. In liver, Per1 mRNA
levels peak at CT10, with translation following at CT15 to CT18.(38)
After phosphorylation in the cytoplasm, PER proteins form a
complex with CRY proteins, which suppresses BMAL:CLOCK
transcription. Bmal is expressed as RNA at CT21 to CT03 and then
translated to protein at CT15 to CT03.(38) Recently, Koike and
colleagues(39) showed that BMAL:CLOCK transcriptional activity
peaks at CT15 and decreases at CT16 to CT20. In our study,
maximummineral deposition occurs from CT13 to CT22, strongly
suggesting that mineralization is associated with BMAL:CLOCK
transcriptional activity. Ours is the ﬁrst study to directly demon-
strate a correlation between peripheral clock operation and bone
mineralization. Moreover, because the master clock in the SCN is
not present, we have shown that circadian regulation of mineral
deposition is an autonomous process in organ culture, although
presumably synchronized by the master clock in intact organisms.
Development of mineral crystallinity does not appear to be
directly regulated by a clock. Instead, small apatitic crystals
continuously grow larger, at least along the crystallographic c‐
axis. Mineral crystallinity increases approximately linearly with
time before plateauing. Intermediate crystal phases such as
amorphous calcium phosphate or octacalcium phosphate that
have been proposed in more controlled systems were not
detected.(28,40) As reviewed by Gorski,(26,41) the mineralization
process can be considered as having two parts: (1) a nucleation
phase in which crystallites of 15 to 20 nm in size are deposited
into the extracellular matrix (ECM); and (2) a growth phase during
which individual crystals increase in size. The ﬁrst detected
mineral in the present study had a crystallinity of 14 nm. Because
it forms within a previously unmineralized fontanel region
adjacent to themineralization front, thismineralmust result from
de novo nucleation. After several days of increasing crystallinity a
plateau of about 22 nm was reached. Our experiments strongly
suggest that the nucleation process is governed by circadian
oscillatory signaling, but the increase in crystallite size is not, at
least over the 5‐day to 6‐day durations of our measurements. For
crystallites to propagate into the nonmineralized matrix both
nucleation and crystal growth are required. We are observing
both. However, we have no evidence about what protein or
proteins mediate this process.
There is currently no consensus on a mechanism for limiting
crystal growth to a certain size. Possibilities include the
suggested timed expression of crystal growth inhibitors and
the limited volume of type I collagen gap regions.(25,42) However,
crystal growth of apatites in vitro has also been shown to be
limited by crystal ionic composition.(43) Carbonate substitution
destabilizes an apatitic crystal lattice and limits crystals to a
maximum size. Regulation of mineral crystallinity may not
involve direct interaction with proteins, but rather occurs
through regulation of carbonate, phosphate, or calcium
concentration in the ECM.
There are limitations to our study. Importantly, for every tissue
specimen we chose a measurement region at the mineralization
front at the start of an experiment. This same region is
interrogated throughout the experiment, but the mineralization
front continues to advance. Thus, at the ﬁrst measurement time
wemay seemineral deposition on newly laid downmatrix, but all
subsequent measurements are of new mineral deposited on
preexisting mineral. In short, as the experiment proceeds it
becomes increasingly difﬁcult to see any details of ﬁrst mineral.
Transient mineral intermediates, if any, are obscured by the
earlier‐deposited mineral.
Our experimental apparatus does not allowobservationofmineral
deposition and luminescence in the same experiment. Raman
spectroscopy requires use of a high‐magniﬁcation/high‐NAobjective
to maximize observation of a thin layer of newly modeled mineral.
But weak luminescence measurement requires a low‐magniﬁcation
objective to collect signal from a large area of the specimen.
Although automation of change of objectives is possible, the
instrumentation available for this study does not have this capability.
Although our results imply that any osteoblast‐directed
ossiﬁcation is governed by circadian processes, current measure-
ments were only made in calvarial intramembranous bone. We
provide no direct evidence that circadian rhythms occur in
endochondral ossiﬁcation. We also do not know how circadian
processes interact with genetic defects affecting the amount and
quality of mineral.(44,45) Our specimen immobilizer was designed
for disk‐shaped specimens. Completely different design would
be needed for study of endochondral ossiﬁcation in ribs or long
bones. Even at its present state of development or with simple
instrument modiﬁcations our model may be applicable to study
of therapeutic interventions to bone resorption and formation
that may disrupt the circadian processes. However, anabolic
treatments that target osteoblast activity are more likely to
disrupt circadian rhythms in osteogenesis. Luchavova and
colleagues(46) showed that once‐daily injections of teriparatide
Fig. 5. Circular graphic showing circadian Per1 expression and bone
mineralization. Circadian time, inner circle. Median Per1 expression and
mineralization times shown as dark gray circle and light gray triangle,
with bars representing the standard deviation. Dark region indicates
lights off time during gestation.
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(PTH(1‐34)) induced twice‐daily peaks in bone turnover markers.
A less frequent dose is required for treatment with sclerostin
antibody; however, its effect on circadian mineralization has not
been determined. Anticatabolic treatment with bisphospho-
nates in rats reduces the daily resorption of bone, but shows no
sign of perturbing the circadian pattern and has no effect on
bone formation marker magnitude or frequency.(47) However, it
is not known if the lack of Haversian systems in this lower bone
turnover animal model would affect the interpretation of this
result.
In summary, this study provides further details of the circadian
rhythm of bone formation including evidence for oscillatory
behavior of mineralization. Based on the current evidencewe see
no other explanation for periodic behavior in these calvarial
explants than the intervention of a local circadian mechanism in
intramembranous ossiﬁcation, particularly in the nucleation of
apatitic mineral. It is not clear at this point whether circadian
signaling also plays a role in mineral propagation and
crystallinity; however, the data here suggest no inﬂuence.
Because our measurements are made on ex vivo specimens, it
remains possible that diurnal synchronization by the master
clock will affect details of our ﬁndings if such measurement were
to be made on live animals.
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